698 Views | 138 Downloads
Correspondence: Kerry J. Ressler, MD, PhD, Department of Psychiatry and Behavioral Sciences, Yerkes Research Center, Emory University, 954 Gatewood Drive, Atlanta, GA 30329; Email: kressle@emory.edu.
Acknowledgments: We thank the participants who graciously shared their stories and their time, and our colleagues Allen Graham, India Karapanou, Angelo Brown, Lamya Koury, Lauren Sands, Justine Phifer, Daniel Crain, Nineequa Blanding, Betsy Crowe, Dorothie Ortigo, Kyle Ortigo, and Kate Thomas for excellent assistance and support.
Disclosures: Drs Wingo and Bradley have no relevant potential conflicts of interest.
Dr. Ressler has received funding support related to other studies from Lundbeck, NARSAD, Burroughs Wellcome Foundation, NIMH, NIDA, and is a founder of Extinction Pharmaceuticals for NMDA-based therapeutics.
This work was supported by a research fellowship award from the American Psychiatric Institute for Research & Education and an NIH grant UL RR025008 (to APW) and the National Institutes of Mental Health (MH071537).
Support was also received from the Emory and Grady Memorial Hospital General Clinical Research Center, NIH National Centers for Research Resources (M01RR00039), the American Foundation for Suicide Prevention (BB) and the Burroughs Wellcome Fund (KJR).
© 2010 Wiley‐Liss, Inc.